Brief: Guardant Health Q1 Adjusted EPS USD -0.49 Vs. IBES Estimate USD -0.81
30/04/2025 21:05
Apr 30 (Reuters) - Guardant Health Q1 revenue USD 203.5 million vs. IBES estimate USD 190.1 million. Q1 EPS USD -0.77 Q1 adjusted net income USD -61.1 million vs. IBES estimate USD -94.3 million Q1 adjusted EBITDA USD -58.5 million vs. IBES estimate USD -66.5 million outlook FY revenue USD 880-890 million
Recent news on Guardant Health
See all newsU.S. RESEARCH ROUNDUP-CF Industries, Kimberly-Clark, Welltower
U.S. RESEARCH ROUNDUP- Adobe, Caseys General Stores, Oracle
U.S. STOCKS ON THE MOVE-Intel, Victoria's Secret, Super Micro
U.S. STOCKS ON THE MOVE-Novo Nordisk, Intel, Oracle
U.S. STOCKS ON THE MOVE-Enliven Therapeutics, DXC Technology, Humacyte